Lee Hambright
Stock Analyst at Bernstein
(3.53)
# 891
Out of 5,115 analysts
39
Total ratings
58.62%
Success rate
5.36%
Average return
Main Sectors:
Stocks Rated by Lee Hambright
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| ABT Abbott Laboratories | Maintains: Outperform | $154 → $125 | $109.30 | +14.36% | 7 | Jan 23, 2026 | |
| ISRG Intuitive Surgical | Maintains: Outperform | $740 → $750 | $504.22 | +48.74% | 4 | Jan 23, 2026 | |
| MDLN Medline | Initiates: Outperform | $49 | $44.20 | +10.86% | 1 | Jan 12, 2026 | |
| ZBH Zimmer Biomet Holdings | Maintains: Market Perform | $97 → $99 | $87.07 | +13.70% | 2 | Jan 9, 2026 | |
| TNDM Tandem Diabetes Care | Maintains: Market Perform | $18 → $25 | $19.89 | +25.69% | 2 | Jan 9, 2026 | |
| SYK Stryker | Maintains: Outperform | $450 → $465 | $369.56 | +25.83% | 4 | Jan 9, 2026 | |
| PODD Insulet | Maintains: Outperform | $410 → $380 | $255.81 | +48.55% | 2 | Jan 9, 2026 | |
| MDT Medtronic | Maintains: Outperform | $111 → $112 | $102.96 | +8.78% | 4 | Jan 9, 2026 | |
| JNJ Johnson & Johnson | Maintains: Market Perform | $193 → $208 | $227.25 | -8.47% | 6 | Jan 9, 2026 | |
| DXCM DexCom | Maintains: Outperform | $84 → $86 | $73.04 | +17.74% | 3 | Jan 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $92 → $100 | $93.53 | +6.92% | 1 | Oct 24, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgrades: Outperform | $132 → $135 | $81.36 | +65.93% | 3 | Mar 16, 2022 |
Abbott Laboratories
Jan 23, 2026
Maintains: Outperform
Price Target: $154 → $125
Current: $109.30
Upside: +14.36%
Intuitive Surgical
Jan 23, 2026
Maintains: Outperform
Price Target: $740 → $750
Current: $504.22
Upside: +48.74%
Medline
Jan 12, 2026
Initiates: Outperform
Price Target: $49
Current: $44.20
Upside: +10.86%
Zimmer Biomet Holdings
Jan 9, 2026
Maintains: Market Perform
Price Target: $97 → $99
Current: $87.07
Upside: +13.70%
Tandem Diabetes Care
Jan 9, 2026
Maintains: Market Perform
Price Target: $18 → $25
Current: $19.89
Upside: +25.69%
Stryker
Jan 9, 2026
Maintains: Outperform
Price Target: $450 → $465
Current: $369.56
Upside: +25.83%
Insulet
Jan 9, 2026
Maintains: Outperform
Price Target: $410 → $380
Current: $255.81
Upside: +48.55%
Medtronic
Jan 9, 2026
Maintains: Outperform
Price Target: $111 → $112
Current: $102.96
Upside: +8.78%
Johnson & Johnson
Jan 9, 2026
Maintains: Market Perform
Price Target: $193 → $208
Current: $227.25
Upside: -8.47%
DexCom
Jan 9, 2026
Maintains: Outperform
Price Target: $84 → $86
Current: $73.04
Upside: +17.74%
Oct 24, 2024
Maintains: Outperform
Price Target: $92 → $100
Current: $93.53
Upside: +6.92%
Mar 16, 2022
Upgrades: Outperform
Price Target: $132 → $135
Current: $81.36
Upside: +65.93%